| Literature DB >> 28163920 |
Takeshi Kitamoto1, Masanobu Tsuda2, Masaki Kato1, Fukuki Saito3, Yoshito Kamijo4, Toshihiko Kinoshita1.
Abstract
AIM: Carbon monoxide (CO) poisoning often manifests delayed neuropsychological sequelae. The risks and preventive factors for the development of delayed neuropsychological sequelae are controversial at present. The purpose of this retrospective study was to assess the risk factors for this condition.Entities:
Keywords: Bedsore; carbon monoxide poisoning; delayed sequelae; risk factor
Year: 2016 PMID: 28163920 PMCID: PMC5256422 DOI: 10.1002/ams2.197
Source DB: PubMed Journal: Acute Med Surg ISSN: 2052-8817
Statistical analyses of risk factors for development of delayed neuropsychological sequelae (DNS) following carbon monoxide poisoning
| Variables | Non‐DNS ( | DNS ( |
| |
|---|---|---|---|---|
| Sex | Male, | 56 | 8 | n.s. |
| Female, | 13 | 4 | ||
| Age, years | 45.9 ± 15.8 | 46.1 ± 14.0 | n.s. | |
| Consciousness level, GCS | 12.1 ± 4.0 ( | 7.3 ± 3.5 ( | <0.001 | |
| Mean blood pressure, mmHg | 101.5 ± 17.6 ( | 94.9 ± 11.3 ( | n.s. | |
| Heart rate, b.p.m. | 104.6 ± 24.8 ( | 98.3 ± 24.3 ( | n.s. | |
| Exposure time, h | 3.5 ± 0.5 ( | 14.6 ± 1.9 ( | <0.001 | |
| COHb, % | 24.4 ± 1.6 ( | 22.1 ± 4.4 ( | n.s. | |
| Lactate, mg/dL | 48.3 ± 46.8 ( | 29.2 ± 22.4 ( | n.s. | |
| Base excess, mEq/L | −2.6 ± 5.5 ( | −3.7 ± 4.5 ( | n.s. | |
| CK, IU/L | 397.1 ± 851.9 ( | 5845.9 ± 8722.1 ( | <0.001 | |
| Abnormality in head imaging study | 10/69 | 7/11 | <0.001 | |
| Occurrence of bedsores | 3/64 | 6/12 | <0.001 | |
| Poisoning from burning charcoal | 38/69 | 11/12 | <0.050 | |
Continuous variables are shown as mean value ± SD. COHb, carboxyhemoglobin; CK, creatinine phosphokinase; GCS, Glasgow Come Scale; n.s., not significant.
Detailed characteristics of patients who developed delayed neuropsychological sequelae (DNS) following carbon monoxide (CO) poisoning
| Case | Exposure time, h | Time interval of CO exposure and DNS, days | GCS score | COHb, % | CK, IU/L | Abnormality in head image | |
|---|---|---|---|---|---|---|---|
| Sex | Age, years | ||||||
| F | 36 | 18 | 23 | 3 | 20.8 | 1,269 | Yes (BG, WM) |
| M | 41 | 12 | 11 | 5 | 28.9 | 1,829 | Yes (BG, WM) |
| M | 49 | – | 21 | 9 | 3.4 | 4,635 | Yes (BG, WM) |
| M | 68 | – | 14 | 5 | 2.1 | 8,514 | None |
| F | 53 | 11 | 27 | – | 28.6 | 3,153 | None |
| F | 37 | 24 | 31 | 7 | 35.8 | 34 | None |
| M | 48 | 14 | 34 | 9 | 46.8 | – | Yes (WM) |
| M | 59 | 9 | 23 | 14 | – | 2,174 | Not performed |
| M | 40 | – | 35 | 5 | 20.2 | 31,125 | None |
| M | 68 | – | 22 | 11 | 22.2 | 1,372 | Yes (BG, WM) |
| F | 26 | 14 | 42 | 3 | 12 | 5,547 | Yes (BG) |
| M | 28 | – | 37 | 9 | – | 4,652 | Yes (BG) |
–, no data. BG, basal ganglion, CK, creatinine phosphokinase; COHb, carboxyhemoglobin; F, female; GCS, Glasgow Come Scale; M, male; WH, white matter.